Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.

Site
Oxford
Pubmed id
25101911
Authors

Mohedas A, Wang Y, Sanvitale CE, Canning P, Choi S, Xing X, Bullock AN, Cuny GD, Yu PB

DOI
10.1021/jm501177w
Journal
J. Med. Chem.
Publication Date
2014-8-7
Year
2014
N Publication Date
Validated
Y